Acadia prices 8.3 million public offering Acadia Healthcare Business, Inc. today announced a public offering of 8,333,333 shares of its common share, pursuant to a registration declaration filed with the Securities and Exchange Commission . Acadia will grant the underwriters a choice to acquire yet another 1,249,999 shares to cover over-allotments, if any. All the shares in the giving shall be sold by Acadia. Jefferies & Company, Inc. And Citigroup shall serve as joint book-working managers in the offering. Raymond James & Associates, Inc., RBC Capital Markets, Avondale and LLC Partners, LLC are performing as co-managers.Among topics in the delayed-insertion group who by no means received an IUD, the most typical alternative choices for contraception had been condoms no method . During the 6 months of follow-up, there were simply no pregnancies in the immediate-insertion group, as compared with five in the delayed-insertion group , all among ladies who never received an IUD. Two of the 3 subjects who did not undergo randomization completed the 6-month follow-up; neither received an IUD, and one became pregnant. Adverse Events There have been no significant differences between groups in rates of any adverse events, including pelvic infection .